Medicine and Health

XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection

P. P. Gerber, M. J. Donde, et al.

This groundbreaking study by Pehuén Pereyra Gerber, Maria J. Donde, Nicholas J. Matheson, and Alexander I. Taylor highlights the innovative design and effectiveness of RNA endonuclease XNAzymes in cleaving SARS-CoV-2 RNA, showcasing their potential as a rapid platform for antiviral reagent generation.... show more

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir

G. Bolcato, M. Bissaro, et al.

Biology

The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms

A. M. Buck, A. N. Deitchman, et al.

Biology

Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient

M. Brandolini, S. Zannoli, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny